The first whole body in-vivo analysis has shown a new radiotracer that can improve medical understanding of inflammation is safe and tolerable in healthy humans.
Medical technology company Prothea Technologies, a spinout of the
universities of Edinburgh and Bath, has announced the enrolment of the
first patient in a Precision Lung clinical trial.
Scotland’s first total-body scanner - set to accelerate drug development and diagnosis for patients - is now in operation at the Royal Infirmary of Edinburgh.
Deep tech semiconductor company Neuranics, a joint spinout between the universities of Edinburgh and Glasgow, has raised $8 million to accelerate global growth and commercial adoption of its magnetic sensing technology.
Data scientists and clinical researchers are working with high street opticians for the first time to develop a digital tool that can predict a person’s risk of dementia from a routine eye test.
